4.09
price down icon2.85%   -0.12
after-market After Hours: 4.08 -0.010 -0.24%
loading
Prime Medicine Inc stock is traded at $4.09, with a volume of 1.87M. It is down -2.85% in the last 24 hours and up +69.01% over the past month. Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
See More
Previous Close:
$4.21
Open:
$4.22
24h Volume:
1.87M
Relative Volume:
0.55
Market Cap:
$550.09M
Revenue:
-
Net Income/Loss:
$-217.44M
P/E Ratio:
-1.8848
EPS:
-2.17
Net Cash Flow:
$-205.20M
1W Performance:
-10.50%
1M Performance:
+69.01%
6M Performance:
+44.52%
1Y Performance:
-27.09%
1-Day Range:
Value
$4.075
$4.263
1-Week Range:
Value
$4.075
$4.815
52-Week Range:
Value
$1.11
$5.94

Prime Medicine Inc Stock (PRME) Company Profile

Name
Name
Prime Medicine Inc
Name
Phone
617-465-0013
Name
Address
60 FIRST ST., CAMBRIDGE
Name
Employee
214
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
PRME's Discussions on Twitter

Compare PRME with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PRME
Prime Medicine Inc
4.09 566.23M 0 -217.44M -205.20M -2.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Prime Medicine Inc Stock (PRME) Upgrades & Downgrades

Date Action Analyst Rating Change
May-27-25 Downgrade Citigroup Buy → Neutral
May-20-25 Downgrade H.C. Wainwright Buy → Neutral
May-20-25 Downgrade JP Morgan Overweight → Neutral
Dec-10-24 Initiated JMP Securities Mkt Outperform
May-20-24 Initiated H.C. Wainwright Buy
May-16-24 Upgrade Citigroup Neutral → Buy
Apr-22-24 Initiated Chardan Capital Markets Buy
Apr-08-24 Initiated TD Cowen Buy
Apr-03-24 Initiated Wedbush Outperform
Jan-16-24 Downgrade Stifel Buy → Hold
Dec-08-23 Initiated Citigroup Neutral
Oct-09-23 Initiated BMO Capital Markets Outperform
Jul-31-23 Initiated Guggenheim Buy
Apr-18-23 Initiated Stifel Buy
Nov-14-22 Initiated Goldman Neutral
Nov-14-22 Initiated JP Morgan Overweight
Nov-14-22 Initiated Jefferies Buy
Nov-14-22 Initiated Morgan Stanley Equal-Weight
View All

Prime Medicine Inc Stock (PRME) Latest News

pulisher
Jul 28, 2025

Prime Medicine’s SWOT analysis: gene editing firm faces cash crunch amid strategic shift - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

Intraday Charts Show Spike in Prime Medicine Inc. ActivityShort Term High Yield Stock Tips for Active Traders - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Prime Medicine Inc.Free Stock Trend Scanner That Work - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is Prime Medicine Inc. company’s growth strategyConsistent double returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

When is Prime Medicine Inc. stock expected to show significant growthBreakthrough investment results - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are Prime Medicine Inc. company’s key revenue driversHigh-impact stock picks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Prime Medicine Inc. stockOutperformance with explosive growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Prime Medicine Inc. stockAchieve consistent profits with smart trading - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Does Prime Medicine Inc. stock perform well during market downturnsExplosive earnings growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Prime Medicine Inc.Get high-impact stock recommendations now - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Prime Medicine Inc. stock price move sharplyFree Real-Time Trading Opportunities - metal.it

Jul 27, 2025
pulisher
Jul 26, 2025

How Prime Medicine Inc. stock performs during market volatilitySmart Return Focused Trading - metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

What drives Prime Medicine Inc. stock priceUnmatched market performance - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Prime Medicine Inc. a good long term investmentFree Capital Growth Strategies - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Is Prime Medicine Inc. stock a good hedge against inflationFree Risk Assessment Services - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 23, 2025

What analysts say about Prime Medicine Inc. stockAccelerated investment success - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Prime Medicine Inc. Stock Analysis and ForecastSkyrocketing profit margins - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Prime Medicine(PRME) Shares Soar 10.65% on Analyst Rating, Funding Boost - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Prime Medicine Surges 18% on Funding Catalyst: Is This the Start of a Biotech Breakout? - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

BMO Capital Maintains a Buy on Prime Medicine (PRME), Sets a $10 PT - MSN

Jul 21, 2025
pulisher
Jul 21, 2025

Prime Medicine stock price target reiterated at $6 by JMP on CF funding - Investing.com Canada

Jul 21, 2025
pulisher
Jul 20, 2025

Prime Medicine (PRME.O) Surges 5.9%: What’s Behind the Intraday Rally? - AInvest

Jul 20, 2025
pulisher
Jul 20, 2025

Prime Medicine (PRME): A High-Conviction Biotech Play with a 154% Upside - AInvest

Jul 20, 2025
pulisher
Jul 18, 2025

10 Hot Penny Stocks to Invest in Now - Insider Monkey

Jul 18, 2025

Prime Medicine Inc Stock (PRME) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Cap:     |  Volume (24h):